Category:
Covid-19
Medications
Stage:
Proposed Idea
Priority:
Normal
Good fit for:
iConquerMS
Summary:
Key Takeaway: Currently, there is no guidance to support COVID-19 antibody testing as part of clinical care. In fact, the US Food and Drug Administration (FDA) states that the antibody test should not be used to assess a person’s level of immunity against COVID-19. For more information on the topic of antibody testing, see here.
Research about COVID-19 continues to provide new information about the virus and its impact on people with MS. The information on this page was accurate at the time it was last updated on July 25, 2023.
SOURCES:
- US FDA: https://www.fda.gov/medical-devices/safety-communications/antibody-testing-not-currently-recommended-assess-immunity-after-covid-19-vaccination-fda-safety/
- Barouch DH. (2022). Covid-19 Vaccines - Immunity, Variants, Boosters. N Engl J Med. Sep 15;387(11):1011-1020. https://www.nejm.org/doi/full/10.1056/NEJMra2206573